Literature DB >> 23540650

Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Stefan Nierkens1, Jurjen Tel, Edith Janssen, Gosse J Adema.   

Abstract

Antigen cross-presentation describes the process through which dendritic cells (DCs) acquire exogenous antigens for presentation on MHC class I molecules. The ability to cross-present has been thought of as a feature of specialized DC subsets. Emerging data, however, suggest that the cross-presenting ability of each DC subset is tuned by and dependent on several factors, such as DC location and activation status, and the type of antigen and inflammatory signals. Thus, we argue that capacity of cross-presentation is not an exclusive trait of one or several distinct DC subtypes, but rather a common feature of the DC family in both mice and humans. Understanding DC subset activation and antigen-presentation pathways might yield improved tools and targets to exploit the unique cross-presenting capacity of DCs in immunotherapy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antigen presentation; cross-presentation; dendritic cell subsets; immunotherapy

Mesh:

Year:  2013        PMID: 23540650      PMCID: PMC4351710          DOI: 10.1016/j.it.2013.02.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  112 in total

1.  The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture.

Authors:  Petra Schnorrer; Georg M N Behrens; Nicholas S Wilson; Joanne L Pooley; Christopher M Smith; Dima El-Sukkari; Gayle Davey; Fiona Kupresanin; Ming Li; Eugene Maraskovsky; Gabrielle T Belz; Francis R Carbone; Ken Shortman; William R Heath; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-28       Impact factor: 11.205

2.  Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway.

Authors:  Edith Janssen; Koichi Tabeta; Michael J Barnes; Sophie Rutschmann; Sara McBride; Keith S Bahjat; Stephen P Schoenberger; Argyrios N Theofilopoulos; Bruce Beutler; Kasper Hoebe
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

3.  NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells.

Authors:  Ariel Savina; Carolina Jancic; Stephanie Hugues; Pierre Guermonprez; Pablo Vargas; Ivan Cruz Moura; Ana-Maria Lennon-Duménil; Miguel C Seabra; Graça Raposo; Sebastian Amigorena
Journal:  Cell       Date:  2006-07-14       Impact factor: 41.582

4.  CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.

Authors:  Maria-Luisa del Rio; Jose-Ignacio Rodriguez-Barbosa; Elisabeth Kremmer; Reinhold Förster
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

5.  Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells.

Authors:  Jason Waithman; Rhys S Allan; Hiroshi Kosaka; Hiroaki Azukizawa; Ken Shortman; Manfred B Lutz; William R Heath; Francis R Carbone; Gabrielle T Belz
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

6.  TLR ligands differentially affect uptake and presentation of cellular antigens.

Authors:  Markus Michael Weck; Frank Grünebach; Daniela Werth; Christian Sinzger; Anita Bringmann; Peter Brossart
Journal:  Blood       Date:  2007-01-11       Impact factor: 22.113

7.  Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells.

Authors:  David Vremec; Meredith O'Keeffe; Hubertus Hochrein; Martina Fuchsberger; Irina Caminschi; Mireille Lahoud; Ken Shortman
Journal:  Blood       Date:  2006-10-12       Impact factor: 22.113

8.  Antigen crosspresentation by human plasmacytoid dendritic cells.

Authors:  Guillaume Hoeffel; Anne-Claire Ripoche; Diana Matheoud; Michelina Nascimbeni; Nicolas Escriou; Pierre Lebon; Farhad Heshmati; Jean-Gérard Guillet; Monique Gannagé; Sophie Caillat-Zucman; Nicoletta Casartelli; Olivier Schwartz; Henri De la Salle; Daniel Hanau; Anne Hosmalin; Concepción Marañón
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

9.  Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake.

Authors:  Daniel Benitez-Ribas; Gosse J Adema; Gregor Winkels; Ina S Klasen; Cornelis J A Punt; Carl G Figdor; I Jolanda M de Vries
Journal:  J Exp Med       Date:  2006-06-19       Impact factor: 14.307

10.  Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells.

Authors:  Anita Sapoznikov; Jens A A Fischer; Tami Zaft; Rita Krauthgamer; Andrzej Dzionek; Steffen Jung
Journal:  J Exp Med       Date:  2007-07-23       Impact factor: 14.307

View more
  55 in total

1.  In vitro platform establishes antigen-specific CD8+ T cell cytotoxicity to encapsulated cells via indirect antigen recognition.

Authors:  Ying Li; Anthony W Frei; Ethan Y Yang; Irayme Labrada-Miravet; Chuqiao Sun; Yanan Rong; Magdalena M Samojlik; Allison L Bayer; Cherie L Stabler
Journal:  Biomaterials       Date:  2020-06-15       Impact factor: 12.479

2.  Generation of a cord blood-derived Wilms Tumor 1 dendritic cell vaccine for AML patients treated with allogeneic cord blood transplantation.

Authors:  Colin de Haar; Maud Plantinga; Nina Jg Blokland; Niek P van Til; Thijs Wh Flinsenberg; Viggo F Van Tendeloo; Evelien L Smits; Louis Boon; Lotte Spel; Marianne Boes; Jaap Jan Boelens; Stefan Nierkens
Journal:  Oncoimmunology       Date:  2015-05-27       Impact factor: 8.110

Review 3.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

4.  Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.

Authors:  Chunmei Fu; Peng Peng; Jakob Loschko; Li Feng; Phuong Pham; Weiguo Cui; Kelvin P Lee; Anne B Krug; Aimin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-02       Impact factor: 11.205

5.  Plasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.

Authors:  Emily A Hemann; Louisa E Sjaastad; Ryan A Langlois; Kevin L Legge
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

6.  Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometry.

Authors:  Cassandra M Hennies; Maria A Lehn; Edith M Janssen
Journal:  J Immunol Methods       Date:  2015-05-09       Impact factor: 2.303

7.  Enhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.

Authors:  Scott N Furlan; Rajakumar Mandraju; Travis Brewer; Kole Roybal; Ty Dale Troutman; Wei Hu; Noah W Palm; Arun Unni; Chandrashekhar Pasare
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

8.  Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.

Authors:  Jian-Ming Li; Christopher T Petersen; Jing-Xia Li; Reema Panjwani; Daniel J Chandra; Cynthia R Giver; Bruce R Blazar; Edmund K Waller
Journal:  Cancer Res       Date:  2016-09-26       Impact factor: 12.701

9.  Engaging adaptive immunity with biomaterials.

Authors:  Carolina Mora-Solano; Joel H Collier
Journal:  J Mater Chem B       Date:  2014-05-07       Impact factor: 6.331

10.  Distinct activation of primary human BDCA1(+) dendritic cells upon interaction with stressed or infected β cells.

Authors:  B M Schulte; E D Kers-Rebel; R Bottino; J D Piganelli; J M D Galama; M A Engelse; E J P de Koning; G J Adema
Journal:  Clin Exp Immunol       Date:  2016-03-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.